Cargando…
Ineffective Absorption? Failure of Direct-Acting Therapy for Chronic Hepatitis C in Cirrhotic Patients With Roux-en-Y Gastric Bypass
In this era of direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection, treated patients have extremely high rates of sustained virologic response to short courses of therapy regardless of stage of fibrosis. Treatment failure is uncommon and often attributed to medication...
Autores principales: | Tow, Clara Y., Reinus, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587385/ https://www.ncbi.nlm.nih.gov/pubmed/31216918 http://dx.doi.org/10.1177/2324709619858127 |
Ejemplares similares
-
How Sustained is Roux-en-Y Gastric Bypass Long-term Efficacy?: Roux-en-Y Gastric Bypass efficacy
por: Guimarães, Marta, et al.
Publicado: (2021) -
Failure of Mesenteric Defect Closure After Roux-en-Y Gastric Bypass
por: Hope, William W., et al.
Publicado: (2010) -
Management of a refractory marginal ulcer following Roux-en-Y gastric bypass with EUS-guided Roux-en-Y gastric bypass reversal
por: Kerbage, Anthony, et al.
Publicado: (2023) -
Laparoscopic Roux-en-“W” Gastric Bypass
por: Rovito, Peter E.
Publicado: (2004) -
Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity
por: Nguyen, Ninh T., et al.
Publicado: (1999)